Rapid progress has been made in the development of new diagnostic assays for
tuberculosis in recent years. New technologies have been developed and assessed, and …

About 1· 3 million people died of tuberculosis in 2012, despite availability of effective drug
treatment. Barriers to improvements in outcomes include long treatment duration (resulting …

Recent data for the global burden of disease reflect major demographic and lifestyle
changes, leading to a rise in non-communicable diseases. Most countries with high levels of …

Abstract Coronavirus disease 2019 (COVID-19) is an acute infection of the respiratory tract
that emerged in late 2019,. Initial outbreaks in China involved 13.8% of cases with severe …

2019-nCoV Transmission from Asymptomatic Patient In this report, investigators in Germany
detected the spread of the novel coronavirus (2019-nCoV) from a person who had recently …

Summary Background The Xpert MTB/RIF test for tuberculosis is being rolled out in many
countries, but evidence is lacking regarding its implementation outside laboratories, ability to …

The characteristics of loop-mediated isothermal amplification (LAMP) make it a promising
platform for the molecular detection of tuberculosis (TB) in developing countries. Here, we …

Generalist and specialist species differ in the breadth of their ecological niches. Little is
known about the niche width of obligate human pathogens. Here we analyzed a global …

Although it has been long asserted that family businesses hold advantages over nonfamily
businesses, to date, there have been very few theories developed as to exactly why family …

Background Tuberculosis is the world's leading infectious disease killer. We aimed to
identify shorter, safer drug regimens for the treatment of tuberculosis. Methods We did a …